enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
7.05
-1.63 (-18.78%)
At close: Mar 9, 2026, 4:00 PM EDT
7.52
+0.47 (6.67%)
After-hours: Mar 9, 2026, 5:50 PM EDT
enGene Holdings Market Cap
enGene Holdings has a market cap or net worth of $472.28 million as of March 9, 2026. Its market cap has increased by 51.38% in one year.
Market Cap
472.28M
Enterprise Value
229.79M
1-Year Change
51.38%
Ranking
Category
Stock Price
$7.05
Market Cap Chart
Since February 1, 2022, enGene Holdings's market cap has increased from $155.91M to $472.28M, an increase of 202.91%. That is a compound annual growth rate of 31.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 581.47M | -3.87% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 523.79M |
| Lyell Immunopharma | 523.66M |
| Immix Biopharma | 520.10M |
| Rigel Pharmaceuticals | 519.46M |
| Forte Biosciences | 518.18M |
| Fulcrum Therapeutics | 512.82M |
| ADC Therapeutics | 509.22M |
| Contineum Therapeutics | 507.93M |